IR News
サブ-ナビゲーション
  • Premier Anti-Aging
  • PRODUCT
  • COMPANY
  • IR
    • Management Information
    • Financial Information
    • IR Library
    • Stock Information
    • IR Calendar
    • 現在位置:IR News
    • IR - Frequently Asked Questions
    • Inquiries from Shareholders and Investors (IR)
    • Disclaimer
  • SUSTAINABILITY
  • SAFETY
  • CONTACT

IR News

  • 2025.03.28 [Delayed] Corporate Report 2025 pdf （6,513KB）
  • 2025.03.18 FY2025 2Q Results Briefing Q&A for the Fiscal Year Ending July 2025 pdf （240KB）
  • 2025.03.18 FY2025 2Q Results Briefing Video
  • 2025.03.13 FY2025 2Q Results Briefing Material pdf （2,556KB）
  • 2025.03.13 Consolidated Financial Results for the First Six Months of the Fiscal Year Ending July 31, 2025 pdf （369KB）
  • 2025.03.13 Notice concerning difference between interim consolidated earnings forecasts and actual results for the six months ended January 31, 2025 pdf （143KB）
  • 2025.02.13 A new brand that realizes fast beauty medical concept, Lalaskin, is born! Advance sale on April 11, 2025, nationwide release on September 19, 2025. pdf （459KB）
  • 2024.12.18 FY2025 1Q Results Briefing Q&A for the Fiscal Year Ending July 2025 pdf （240KB）
  • 2024.12.17 FY2025 1Q Results Briefing Video
  • 2024.12.13 FY2025 1Q Results Briefing Material pdf （2,977KB）
  • 2024.12.13 Consolidated Financial Results for the First Three Months of the Fiscal Year Ending July 31, 2025 pdf （720KB）
  • 2024.11.13 Notice concerning the determination of conditions for issuance of stock options pdf （162KB）
  • 2024.10.30 Business Plan and Growth Potential Explanatory Material pdf （2,500KB）
  • 2024.10.30 Corporate Governance Report pdf （800KB）
  • 2024.10.29 Notice concerning issuance of stock options (stock acquisition rights) pdf （250KB）
  • 2024.10.17 [Delayed]DUO “The Cleansing Balm” Renewal Release pdf （439KB）
  • 2024.09.18 FY2024 Results Briefing Q&A for the Fiscal Year Ending July 2024 pdf （232KB）
  • 2024.09.18 FY2024 Results Briefing Video
  • 2024.09.12 FY2024 Results Briefing Material pdf （3,019KB）
  • 2024.09.12 Consolidated Financial Results for the Fiscal Year Ended July 31, 2024 pdf （660KB）
  • 2024.09.12 Notice concerning withdrawal of the medium-term management plan 2024-2027 +Beyond pdf （170KB）
  • 2024.09.12 Notice concerning difference between consolidated earnings forecasts and actual results pdf （204KB）
  • 2024.09.12 Notice concerning stock options (stock acquisition rights) pdf （179KB）
  • 2024.09.12 Notice concerning proposals for the election of deirectors and auditors pdf （165KB）
  • 2024.06.20 FY2024 3Q Results Briefing Video
  • 2024.06.17 FY2024 3Q Results Briefing Q&A for the Fiscal Year Ending July 2024 pdf （206KB）
  • 2024.06.13 Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending July 31, 2024 pdf （659KB）
  • 2024.06.13 FY2024 3Q Results Briefing Material pdf （3,222KB）
  • 2024.03.21 FY2024 2Q Results Briefing Video
  • 2024.03.19 FY2024 2Q Results Briefing Q&A for the Fiscal Year Ending July 2024 pdf （277KB）
  • 2024.03.14 Notice concerning difference between earnings forecasts and actual results for 1H and revision of full year earnings forecasts for FY2024 pdf （174KB）
  • 2024.03.14 FY2024 2Q Results Briefing Material pdf （2,479KB）
  • 2024.03.14 Consolidated Financial Results for the First Six Months of the Fiscal Year Ending July 31, 2024 pdf （462KB）
  • 2023.12.19 FY2024 1Q Results Briefing Q&A for the Fiscal Year Ending July 2024 pdf （212KB）
  • 2023.12.19 FY2024 1Q Results Briefing Video
  • 2023.12.14 FY2024 1Q Results Briefing Material pdf （2,269KB）
  • 2023.12.14 Consolidated Financial Results for the First Three Months of the Fiscal Year Ending July 31, 2024 pdf （475KB）
  • 2023.12.14 Notice concerning change in reporting segments pdf （118KB）
  • 2023.11.01 Notice concerning completion of absorption-type merger (simplified merger/short form merger) of wholly owned subsidiary pdf （253KB）
  • 2023.10.30 Corporate Governance Report pdf （711KB）
  • 2023.10.30 Business Plan and Growth Potential Explanatory Material pdf （3,579KB）
  • 2023.09.21 FY2023 Results Briefing Q&A for the Fiscal Year Ending July 2023 pdf （354KB）
  • 2023.09.21 FY2023 Results and Medium-Term Management Plan Briefing Video
  • 2023.09.19 Partial Corrections to Notice Concerning Partial Amendment to the Articles of Incorporation pdf （256KB）
  • 2023.09.14 Announcement on Formulation of Medium Term Management Plan [2024-2027+Beyond] pdf （1,935KB）
  • 2023.09.14 Medium-Term Management Plan pdf （1,694KB）
  • 2023.09.14 Notice Concerning Partial Amendment to the Articles of Incorporation and Proposal for Election of Directors pdf （281KB）
  • 2023.09.14 FY2023 Full Year Results pdf （2,956KB）
  • 2023.09.14 Consolidated Financial Results for the Fiscal Year Ended July 31,2023 pdf （549KB）
  • 2023.09.14 Notice Concerning Establishment of New Corporate Identity (CI) pdf （447KB）
  • 2023.09.14 Notice concerning recording of corporate tax adjustments pdf （251KB）
  • 2023.09.14 Notice concerning absorption-type merger (simplified merger/short form merger) of wholly owned subsidiary and waiver of loan receivables pdf （325KB）
  • 2023.09.14 Notice Concerning Head Office Relocation pdf （259KB）
  • 2023.08.29 Corporate Report 2023 pdf （4,164KB）
  • 2023.06.16 FY2023 3Q Results Briefing Q&A for the Fiscal Year Ending July 2023 pdf （896KB）
  • 2023.06.16 FY2023 3Q Results Briefing Video
  • 2023.06.14 FY2023 3Q Results Briefing Material pdf （2,848KB）
  • 2023.06.14 Consolidated Financial Results for the First Nine Months of the Fiscal Year Ending July 31, 2023 pdf （339KB）
  • 2023.06.14 Notice Concerning Revision of Earnings Forecasts pdf （664KB）
  • 2023.04.14 Notice Concerning Formulation of Basic Sustainability Policy and Identification of Materiality pdf （598KB）
  • 2023.03.17 FY2023 2Q Results Briefing Q&A for the Fiscal Year Ending July 2023 pdf （194KB）
  • 2023.03.16 FY2023 2Q Results Briefing Video
  • 2023.03.14 FY2023 2Q Results Briefing Material pdf （4,343KB）
  • 2023.03.14 Consolidated Financial Results for the First Six Months of the Fiscal Year Ending July 31, 2023 pdf （394KB）
  • 2023.03.14 Notice Concerning Differences Between Consolidated Earnings Forecasts and Results pdf （371KB）
  • 2023.02.01 Notice Concerning New Management System of Our Subsidiary pdf （176KB）
  • 2023.01.31 Notice Concerning Completion of Share Acquisition of Venex Co., Ltd. pdf （174KB）
  • 2023.01.17 Notice Concerning Acquisition of Shares of Venex Co., Ltd. pdf （193KB）
  • 2023.01.17 Supplementary Materials on the Acquisition of Shares of Venex Co., Ltd. pdf （1,006KB）
  • 2022.12.19 FY2023 1Q Results Briefing Q&A for the Fiscal Year Ending July 2023 pdf （199KB）
  • 2022.12.19 Notice of year-end and New Year holidays
  • 2022.12.16 FY2023 1Q Results Briefing Video
  • 2022.12.14 FY2023 1Q Results Briefing Material pdf （3,442KB）
  • 2022.12.14 Consolidated Financial Results for the First Three Months of the Fiscal Year Ending July 31, 2023 pdf （666KB）
  • 2022.12.14 Notice Concerning Rivision of Earnings Forecasts pdf （378KB）
  • 2022.10.31 Corporate Governance Report pdf （485KB）
  • 2022.10.31 Business Plan and Growth Potential Explanatory Material pdf （3,922KB）
  • 2022.09.16 Full Year Results Briefing Material for the Fiscal Year Ended July 2022（Scripts, Q&A included） pdf （1,008KB）
  • 2022.09.13 Full Year Results Briefing Material for the Fiscal Year Ended July 2022 pdf （2,543KB）
  • 2022.09.13 Consolidated Financial Results for the Fiscal Year Ended July 31, 2022 pdf （432KB）
  • 2022.09.06 Notice concerning sales launch date of a new brand Reinca with ENGY Stem S pdf （1,152KB）
  • 2022.09.02 Notice Concerning Results of Joint Research between the University of Tokyo and Consolidated Subsidiary pdf （401KB）
  • 2022.07.06 Notice concerning sales launch date of a new brand "Ko" with CBD (Cannabidiol) as a core ingredient, at a consolidated subsidiary pdf （333KB）
  • 2022.06.17 FY2022 3Q Results Briefing Material（Scripts, Q&A included） pdf （1,237KB）
  • 2022.06.03 The announcement regarding an exclusive license agreement with sublicensing rights , incorporating DDS technology DehydraTECH ™ by the consolidated subsidiary company pdf （514KB）
  • 2022.03.14 FY2022 2Q Results Briefing Material pdf （2,872KB）
  • 2021.12.17 FY2022 1Q Results Briefing Material pdf （4,732KB）
  • 2021.09.17 FY2021 4Q Results Briefing Material pdf （3,222KB）
  • 2021.06.18 FY2021 3Q Results Briefing Material pdf （5,466KB）
  1. Premier Anti-Aging
  2. IR
  3. IR News
  • gnavi
  • navi-3way
  • JP
  • EN

ページの先頭へ
ページの先頭へ
  • CLOSE
  • MENU

サイト内検索

Cookie Policy

We use cookies to provide you with a better browsing experience.
Please confirm that you agree to our use of cookies by clicking Yes.
If you continue to browse this website even without agreeing to our use of cookies,
we consider that you have consented to our use of cookies.

Privacy Policy

Yes

  • footer-content